HK1215969A1 - 用於检测抗生物制品治疗的中和性自身抗体的测定 - Google Patents

用於检测抗生物制品治疗的中和性自身抗体的测定 Download PDF

Info

Publication number
HK1215969A1
HK1215969A1 HK16103834.6A HK16103834A HK1215969A1 HK 1215969 A1 HK1215969 A1 HK 1215969A1 HK 16103834 A HK16103834 A HK 16103834A HK 1215969 A1 HK1215969 A1 HK 1215969A1
Authority
HK
Hong Kong
Prior art keywords
neutralizing
therapy
present
biologic
assays
Prior art date
Application number
HK16103834.6A
Other languages
English (en)
Chinese (zh)
Inventor
Scott Hauenstein
Sharat Singh
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/802,117 external-priority patent/US20130266963A1/en
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of HK1215969A1 publication Critical patent/HK1215969A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16103834.6A 2012-11-30 2013-11-27 用於检测抗生物制品治疗的中和性自身抗体的测定 HK1215969A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732251P 2012-11-30 2012-11-30
US61/732,251 2012-11-30
US13/802,117 2013-03-13
US13/802,117 US20130266963A1 (en) 2011-07-06 2013-03-13 Assay for detecting neutralizing autoantibodies to biologic therapy
PCT/IB2013/060458 WO2014083520A2 (en) 2012-11-30 2013-11-27 Assays for detecting neutralizing autoantibodies to biologic therapy

Publications (1)

Publication Number Publication Date
HK1215969A1 true HK1215969A1 (zh) 2016-09-30

Family

ID=50828561

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103834.6A HK1215969A1 (zh) 2012-11-30 2013-11-27 用於检测抗生物制品治疗的中和性自身抗体的测定

Country Status (13)

Country Link
EP (1) EP2926136A2 (cg-RX-API-DMAC10.html)
JP (1) JP2016502091A (cg-RX-API-DMAC10.html)
KR (1) KR20150088890A (cg-RX-API-DMAC10.html)
CN (1) CN105074461A (cg-RX-API-DMAC10.html)
AU (1) AU2013350817A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015012482A2 (cg-RX-API-DMAC10.html)
CA (1) CA2892766A1 (cg-RX-API-DMAC10.html)
HK (1) HK1215969A1 (cg-RX-API-DMAC10.html)
IL (1) IL238995A0 (cg-RX-API-DMAC10.html)
MX (1) MX2015006852A (cg-RX-API-DMAC10.html)
RU (1) RU2015125739A (cg-RX-API-DMAC10.html)
SG (2) SG10201703210XA (cg-RX-API-DMAC10.html)
WO (1) WO2014083520A2 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104634955B (zh) 2009-10-26 2016-09-14 雀巢产品技术援助有限公司 检测抗-tnf药物和自身抗体的试验
WO2012054532A1 (en) 2010-10-18 2012-04-26 Prometheus Laboratories Inc. Methods for determining anti-drug antibody isotypes
WO2013006810A1 (en) 2011-07-06 2013-01-10 Nestec Sa Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha
RU2017122720A (ru) 2014-12-05 2019-01-10 Нестек С.А. Непрямые однородные анализы по изменению подвижности для детекции биологических препаратов в образцах пациента
US11085931B2 (en) 2015-01-09 2021-08-10 W. Health L.P. Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
US11119096B2 (en) 2016-07-08 2021-09-14 W. Health L.P. Universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
WO2018178307A1 (en) 2017-03-31 2018-10-04 Ablynx N.V. Improved immunogenicity assays
CN114902052B (zh) * 2020-01-02 2025-07-18 豪夫迈·罗氏有限公司 Ada应答特异性化测定
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术（北京）有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
CN112730846B (zh) * 2020-12-18 2023-12-15 安渡生物医药(杭州)有限公司 一种用于小鼠血样检测免疫复合物的方法
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
CN117871856A (zh) * 2023-12-15 2024-04-12 首都医科大学附属北京地坛医院 可溶性因子在无症状神经梅毒检测中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104634955B (zh) * 2009-10-26 2016-09-14 雀巢产品技术援助有限公司 检测抗-tnf药物和自身抗体的试验
PL2564202T3 (pl) * 2010-04-29 2016-04-29 Theradiag Sa Sposoby wykrywania przeciwciał przeciw lekowi
WO2012054532A1 (en) * 2010-10-18 2012-04-26 Prometheus Laboratories Inc. Methods for determining anti-drug antibody isotypes
MX343327B (es) * 2011-02-17 2016-11-01 Nestec Sa Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
WO2013006810A1 (en) * 2011-07-06 2013-01-10 Nestec Sa Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha

Also Published As

Publication number Publication date
AU2013350817A1 (en) 2015-06-11
IL238995A0 (en) 2015-07-30
JP2016502091A (ja) 2016-01-21
BR112015012482A2 (pt) 2017-07-11
WO2014083520A2 (en) 2014-06-05
WO2014083520A3 (en) 2014-07-31
CA2892766A1 (en) 2014-06-05
SG11201504097PA (en) 2015-06-29
CN105074461A (zh) 2015-11-18
EP2926136A2 (en) 2015-10-07
KR20150088890A (ko) 2015-08-03
SG10201703210XA (en) 2017-06-29
RU2015125739A (ru) 2017-01-13
MX2015006852A (es) 2015-09-16

Similar Documents

Publication Publication Date Title
WO2014083520A3 (en) Assays for detecting neutralizing autoantibodies to biologic therapy
MX343324B (es) Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
Yin et al. Joint inference about sensitivity and specificity at the optimal cut-off point associated with Youden index
AU2018260845A1 (en) Evaluation and treatment of bradykinin-mediated disorders
MX390772B (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
EP2839266A4 (en) METHOD AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE
MX343328B (es) Analisis para la deteccion de farmacos anti-tnf y anticuerpos.
NZ627443A (en) Biological markers for identifying patients for treatment with vegf antagonists
BR112015001102A2 (pt) método de detecção de câncer, droga ou kit e método de seleção de droga terapêutica
FR2996673B1 (fr) Capteur capacitif pour la detection de presence d'un objet et/ou d'un individu.
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
WO2012018538A3 (en) Bioassays for determining pd-1 modulation
BR112015003046A2 (pt) sistema de neurofeedback, processador de sinal para determinação de uma característica do sinal do sinal do biofeedback medido, método para provisão de um usuário com o neurofeedback e programa de computador.
EP2569635A4 (en) METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY
WO2011146945A3 (en) Alk and ros kinase in cancer
JP2014533372A5 (cg-RX-API-DMAC10.html)
SG10201806729VA (en) Novel assay to detect human periostin
WO2011085057A3 (en) Methods for detecting insulin autoantibody
WO2015049390A3 (en) Kidney disease biomarker
EP3277831A4 (en) BIOSENSOR SYSTEM FOR THE QUICK DETECTION OF ANALYTES
WO2011133036A3 (en) Means and methods for determining risk of cardiovascular disease
WO2012129102A3 (en) Detection and analysis of backlink activity
WO2015077342A3 (en) Detection of arginine methylation of egfr for prediction of resistance to therapy